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Objective: Sleeping less or more than the 7-8h has been associated with mortality in the general 
population, which encompasses diversity in employment status, age and community settings. Since 
sleep patterns of employed individuals may differ to those of their unemployed counterparts, the 
nature of their sleep-mortality relationship may vary. We therefore investigated the association 
between self-reported sleep duration and all-cause mortality (ACM) or cardiovascular disease 
mortality (CVDM) in employed individuals. 
Data sources: Based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses, 
searches between January 1990 and May 2020 were conducted in PubMed, Web of Science and 
Scopus. Inclusion/exclusion criteria: Included were prospective cohort studies of 18–64-year-old 
disease-free employed persons with sleep duration measured at baseline, and cause of death 
recorded prospectively as the outcome. Grey literature, case-control or intervention design studies 
were excluded.  
Data Extraction: Characteristics of the studies, participants, and study outcomes were extracted. The 
quality and risk of bias were assessed using the Newcastle-Ottawa Scale. 
Data synthesis: The pooled relative risks (RR) with 95% confidence intervals (CI) were obtained with 
a random-effects model and results presented as forest plots. Heterogeneity and sensitivity analysis 
were assessed.  
Results: Shorter sleep duration (≤6h) was associated with a higher risk for (ACM) (RR: 1.16, 95% CI: 
1.11-1.22) and CVDM (RR: 1.26, 95% CI: 1.12-1.41) compared to 7-8h of sleep, with no significant 
heterogeneity. The association between longer sleep (≥8h) and ACM (RR: 1.18, 95% CI:1.12-1.23, 
P<0.001) needs to be interpreted cautiously owing to high heterogeneity (I2= 86.0%, P<0.001). 
Conclusion: Interventions and education programs targeting sleep health in the workplace may be 
warranted, based on our findings that employed individuals who report shorter sleep appear to have 
a higher risk for ACM and CVDM.  
 








Non-communicable diseases (NCDs) account for about 71% of deaths globally among working-aged 
adults (35–70y), with cardiovascular disease (CVD) being the leading cause of death (31%).1 Modifiable 
risk factors for NCDs include an unhealthy diet, physical inactivity, alcohol use and tobacco smoking. 
The World Health Organisation’s (WHO) global action plan aims to manage these risks so that NCD-
related deaths can be reduced by 25% by the year 2025.2 The workplace has been identified as a key 
setting for public health action, in which diet and physical activity interventions are primarily used to 
address NCD risk.3 
 
Suboptimal sleep (poor quality, insufficient duration and/or mis-timed) has emerged as an important 
modifiable risk factor for cardiovascular and metabolic diseases.3-8 Notwithstanding the importance 
of sleep timing and quality, we will focus on sleep duration in this study given that much of the 
prospective work relating sleep to mortality relies on sleep duration as an outcome variable. 
Guidelines have been published recommending that adults attain 7-9h9 or at least 7h10 of sleep per 
night for optimal physical and mental health. Acknowledging that not all studies conclusively observe 
associations between sleep duration and health outcomes, longitudinal evidence from systematic 
reviews and meta-analyses indicates that individuals with shorter and longer sleep durations are more 
likely to experience poorer health outcomes compared to those clustered around the group median 
(typically 7-8h).11-15 While organisations such as the American Heart Association and the Center for 
Disease Control and Prevention promote healthy sleep awareness16, 17, sleep is yet to be included as 
one of the WHO’s targeted modifiable risk factors that could enhance health and prevent NCDs.2 Thus 
it is unsurprising that although workplace health programmes, typically delivered in urban settings, 




Working hours, commuting time and even the nature of urban employment may impact sleep. Work 
has been shown to be the dominant waking activity in employees who sleep ≤6h per night.18 Adults 
with longer working hours are more likely to have shorter sleep durations4,6 such that for every 
additional hour spent working beyond the standard eight-hour day, sleep is shortened by about two 
hours.4 Commuters traveling more than 75 minutes may also sleep less compared to those whose 
commute is under 45 minutes6,7 and one study showed that for every hour of commuting, sleep was 
shortened by 15 minutes.19 Furthermore, employees in the manufacturing sector, routine and semi-
routine occupations (e.g. cleaners, receptionists) and in managerial roles have been shown to sleep 
less than those in other occupational groups.6,8 Therefore, extended working hours and fixed work 
schedules that demand consistent wake-times may largely contribute to shorter sleep duration in 
employed adults. On the other hand, unemployment has been linked to at least a two-fold increase in 
longer sleep duration (>9h) compared to those sleeping 7-8h. These studies postulated that the 
sleeping patterns of unemployed individuals are not impinged upon by a fixed work schedule; thus 
having the opportunity to sleep more than employed individuals.20, 21  
 
One might speculate that employees working longer hours might sleep less and be at increased risk 
for CVD, all-cause mortality (ACM) or CVD mortality (CVDM). In a meta‐analysis including data from 
24 occupational cohort studies, employees working >54h per week had a 30% higher risk for stroke 
and a 13% higher risk for CVD compared to those who worked 35-40h.22 Similarly, the incidence of 
diabetes was higher among women working >45h per week compared to those working 35-40h23 One 
study has shown a J-shaped relationship between sleep duration and number of health risk factors in 
employees, with those reporting ≤5h per night likely to present with the most risk factors, and those 
sleeping 7-8h per night with the fewest risk factors.24 It was interesting to note that employees 
sleeping ≥9h per night were at greater risk for hypertension, depression, heart disease and cancer 
compared to those sleeping 7-8h24, possibly suggesting a link between underlying disease and sleep 
4 
 
duration. Since, to the best of our knowledge, no studies have included working hours, sleep duration 
and NCD, CVDM or ACM risk in their analyses, it is unclear whether shorter sleep associated with 
employment translates to increased risk for NCDs or mortality.  
 
Although systematic reviews examining the literature pertaining to sleep duration and mortality have 
been published25-30, none have presented the magnitude of these associations exclusively in employed 
populations. Since the sleep patterns of employed individuals may well differ from those of 
unemployed persons, which may in turn alter the nature of the sleep-CMD or sleep-mortality 
relationship, we see value in focusing exclusively on employed individuals, living in urban areas and 
younger than 65y. Even though studies have shown that sleep health can be promoted in the 
workplace31-33, some organisations feel there is insufficient evidence to make sleep a key component 
of their workplace policies and health promotion programmes. Data emanating from studies like ours 
may help advocate for the inclusion of sleep health in employee wellness programmes. Therefore, the 
aim of this systematic review and meta-analysis was to investigate the association between sleep 





The study was conducted according to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines.34 A standardised search strategy was developed a priori to 
identify published cohort studies that quantified the relationship between sleep duration and risk for 
ACM and CVDM in employed populations. Systematic literature searches were conducted in three 
databases: PubMed, Web of Science and Scopus. The search strategy included terms characterising 
the exposure (e.g. sleep), the outcome (e.g. mortality), and the type of study design (e.g. cohort 
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studies). Details of the complete search terms can be found in Supplementary Table S1. Reference 
lists of included articles were also searched for eligible studies.  
Inclusion and Exclusion Criteria 
The following inclusion criteria were applied: (i) original articles published between January 1990 and 
May 2020 in English, (ii) prospective cohort study designs, (iii) employed individuals (where 
employment and unemployment data were presented separately, only data from employed groups 
were included), 18-65 years and disease-free at baseline from urban settings (iv) sleep duration 
assessed at baseline, measured as either total sleep duration over a 24h period (nocturnal and 
daytime sleep) or exclusively during night-time (nocturnal sleep), (v) cause of death recorded 
prospectively as outcome, (vi) follow-up of at least four years, and (vii) at least three sleep duration 
categories were reported, e.g. ≤6h, 7-8h and ≥9h per night. CVDM was defined in accordance with 
ICD-9 codes 390 - 459 or ICD-10 codes I00–I99.  If insufficient data were reported (e.g. absence of 
relative risk (RR), confidence intervals (CI) or number of cases) additional information was requested 
from the authors of studies eligible for inclusion. Studies were excluded if (i) a case-control or 
intervention design was used, (ii) relevant statistical data could not be accessed or (iii) the outcome 
was not adjusted for potential confounders (examples include: age, ethnicity, gender, marital status, 
education, social class (i.e. education level and job position,35 or the individual’s own current 
occupation36), employment grade (i.e. administrative, professional and executive, or clerical job), 
lifestyle characteristics (e.g. smoking, physical activity, alcohol consumption), medical conditions (e.g. 
diabetes, depression, hypertension, cancer, obesity) or medications. Conference abstracts, other 
published abstracts, and grey literature (e.g. reports, white papers, academic theses or dissertations) 
were not included in this meta-analysis.  
 
Data Extraction  
6 
 
Three authors (DER, TKA and PRP) independently screened titles and abstracts, assessed full-texts for 
eligibility, and extracted the following data from included studies: (i) study characteristics (author 
name, publication date, cohort name, design, setting, sleep exposure, start date, end date and 
duration of follow-up period, inclusion and exclusion criteria, confounders), (ii) participant 
characteristics (sample size, age range, gender, race and/or ethnicity, disease status at baseline), and 
(iii) study outcomes (ACM, CVDM, total number of participants and number of deaths at each level of 
exposure, multivariate adjusted effect estimates, e.g. RR and 95% CIs).  
 
DER, TKA and PRP assessed the quality and risk of bias of included studies using the Newcastle-Ottawa 
Scale (NOS).37 The NOS has three broad categories (patient selection, comparability of study groups, 
and assessment of the outcome) and provides a maximum total score of 9. Disagreements were 
resolved through discussion and consensus and NOS scores for each study are included in Table 1.  
 
Data Synthesis 
The exposure variable used in this meta-analysis was self-reported sleep duration, measured at 
baseline of each included study. The manner in which each included study assessed sleep duration is 
defined in Table 1. The included studies varied in their sleep duration categories for which ACM or 
CVDM statistics were reported (Supplementary Table S2), with three studies presenting statistics on 
sleep duration in three categories35, 36, 38 and two studies presenting data on five categories.39, 40 Four 
of the five studies used a reference sleep duration category in the range of 6-8h (Ferrie, Garde, Heslop, 
Patel) while Rhee et al (2012) originally used their ≥8h group as their reference category. For our meta-
analysis, we used the ACM and CVDM statistics in their original form for the three studies reporting 
on three sleep categories (Garde, Heslop, Rhee), but we re-referenced the data for Rhee et al to their 
6-7h category, to better match the other studies.38 For the two studies in which authors reported five 
sleep duration categories, we collapsed those categories less than the reference group into a single 
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‘shorter sleep’ category and those longer than the reference group into a single ‘longer sleep’ category 
(Supplementary Table S2). Primary outcome variables were ACM and/or CVDM RR with 95% CIs per 
exposure. The most covariate-adjusted risk estimates were used in the meta-analysis. Men and 
women were considered independently among studies that reported gender-specific results. The 
pooled RRs with 95% CIs were obtained with a random-effects model and results presented as forest 
plots.  
 
Heterogeneity among studies was assessed by the I2 statistic, which represents the total variability 
that is attributed to between-study variability.41, 42 When heterogeneity was significant, sensitivity 
analyses was performed to identify the influence of individual studies on the magnitude of the pooled 
estimate. This was achieved by omitting the studies with the greatest weight, one at a time, and 
examining the extent to which inferences were dependent on a particular study. Publication bias was 
not assessed as there were inadequate numbers of included studies to properly measure funnel plot 




Search results and study characteristics 
After identification, exclusion of duplicates and screening, 89 full text articles were assessed for 
eligibility. Eighty-four studies failed to meet the inclusion criteria and were excluded, leaving five 
studies eligible for inclusion and analysis (Figure 1). The general characteristics of the included studies 
are presented in Table 1. The five studies analysed for ACM comprised 116 969 participants from five 
countries: two studies included only men,35, 38 one included only women39 and two reported data on 
men and women combined or separately.36, 40 The three studies analysed for CVDM comprised 19 467 
participants from three countries. One of these studies combined their analysis to include men and 
8 
 
women,40 one study reported only on a male cohort35 and another analysed men and women 
separately.36 The studies used either death certificates or national death registries to determine 
number of deaths in each cohort. Follow-up years for ACM and CVDM ranged from 4-30 years, and 
total NOS scores ranged from 6-8 (average of 7) out of a possible score of 9. All studies originated from 
the USA, Europe or South Korea and used questionnaires to obtain self-reported 24h35, 36, 38, 39 or night-
time40 sleep duration (h). The reference sleep duration ranged from 6-8h, shorter sleep ranged from 
<6 to <7h and longer sleep from ≥8 to >8h (Supplementary Table S2).  
 
Sleep duration and all-cause mortality 
In the pooled analysis, shorter sleep duration was associated with a 16% greater risk for ACM relative 
to the reference sleep duration (P<0.001, Figure 2). Although long sleep duration appeared to be 
associated with an 18% greater risk for ACM compared to the 6-8h sleep duration (P<0.001, Figure 3), 
high heterogeneity (I²=86.0%, P<0.001) and limited number of studies suggest that this pooled 
estimate was not robust and therefore unlikely to be associated with ACM.  
 
Sleep duration and cardiovascular disease mortality 
In the pooled analysis, shorter sleep duration was associated with a 26% greater risk for CVDM relative 
to the reference sleep duration (P<0.001, Figure 4) and heterogeneity was non-significant (45.8%, 





Sensitivity analyses were conducted by omitting the study with the largest weight to the pooled 
analyses. Removing Patel et al. (2004) (relative weight: 61.09%) from the analysis between shorter 
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sleep duration and ACM increased the relative risk (RR: 1.19, 95% CI: 1.11-1.27, P<0.001) with no 
heterogeneity. Patel et al. had the greatest relative weight (53.3%) for the longer sleep duration 
analysis and when omitted, relative risk for ACM (RR: 1.02, 95% CI: 0.96-1.09, P=0.558) and 
heterogeneity decreased and were no longer significant.  
Cardiovascular disease mortality 
Sensitivity analysis was not conducted for the association between shorter sleep duration and CVDM, 
because heterogeneity was not significant (I2=45.8%, P=0.136). Furthermore, sensitivity analysis was 
not needed for longer sleep duration as it was not associated with CVDM. 
 
DISCUSSION 
To the best of our knowledge, this is the first systematic review to describe the association between 
self-reported sleep duration and ACM and CVDM in cohorts of employed persons younger than 65 
years of age living in urban settings. The main finding was that compared to the reference sleep 
duration group, those reporting shorter sleep duration had a 16% greater risk for ACM and a 26% 
greater risk for CVDM.  
 
The association between short sleep duration and ACM has previously been reported in the general 
population.25-27, 29, 30 Compared to such systematic reviews in which the same reference of 7-8h was 
used, shorter sleep had lower relative risks than the present study. For example, one review reported 
a RR of 1.13 (95% CI: 1.09-1.17) for short sleep relative to a reference of 7-8h, but had an extreme 
definition for short sleep duration (≤4h)30. In contrast, the present review showed that by sleeping as 
little as one hour less than the recommended sleep duration of 7-9h, employees may have a 
significantly increased risk for ACM. In another review using the same reference range of 7-8h, shorter 
sleep duration was significantly associated with ACM, but the RR of 1.07 (95% CI: 1.03-1.11) included 
only elderly individuals28, while the present study excluded all cohorts older than 65y. 
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Our finding that shorter, but not longer, sleep duration is associated with higher risk for CVDM 
contrasts with one previous study28 that showed a 43% increased risk for long sleep duration and 
CVDM but no association between short sleep and CVDM. Perhaps age contributes to these disparate 
findings since we report on working-aged adults (<65y) while Da Silva et al. (2016) reported on older 
individuals (>60y). Given the relationship between age and mortality, it is unsurprising that longer 
sleep duration is more strongly associated with ACM and CVDM in older cohorts.29, 43, 44 
 
Another study found an association between short sleep and CVDM in women, but not men, although 
both sexes showed an association between long sleep and CVDM compared to 7h. However, extreme 
sleep duration criteria of ≤4h and ≥10h were used, and participants were exclusively of Asian 
ethnicity.45 Socioeconomic status (SES) may affect the sleep duration and CVDM relationship. Studies 
report that disadvantaged groups who are influenced by factors such as poverty and unemployment 
are more likely to have shorter or longer sleep compared to the recommended 7-9h.46, 47 Grandner et 
al. (2010) hypothesized that sleep may be the mediator between SES and mortality.48 We were not 
able to account for SES in the present study, but future work on this topic would benefit from sub-
analyses accounting for SES. 
 
Potential pathways through which short sleep duration may increase risk for ACM include disruption 
of physiological regulatory pathways49, including those that regulate metabolism50, 51, immunity, 
inflammation, appetite and cardiovascular health.52 These disruptions may manifest as CMD risk 
factors, such as hypertension, hyperglycaemia and obesity, all of which are associated with 
mortality.48, 53, 54  
 
The observation that longer sleep duration was associated with an 18% greater risk for ACM compared 
to an average of 6-8h must be interpreted cautiously since there was high heterogeneity within the 
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pooled estimate, heavily influenced by the Patel et al. (2004) study. Despite the high heterogeneity, 
the present findings show that the direction of the associations are predominantly toward increased 
risk for most of the analysed cohorts. Identifying heterogeneity can be helpful in interpreting and 
explaining study results, and for the planning of future studies. We therefore view this finding as 
exploratory, as presently there are insufficient eligible studies to investigate the sources of such wide 
variation through subgroup analyses.  
 
One might speculate that the high heterogeneity may be attributed to factors such as sex or the 
definition of long sleep duration. For example, there were four times more women than men in this 
meta-analysis (women: n= 83 947; men: n=19 474) for long sleep duration and ACM. We can only 
speculate that this disproportionate representation of sex may have contributed to the significantly 
increased risk for ACM among the long sleepers, as previous studies have shown than women sleeping 
longer than 9h may have a higher risk for ACM compared to men.55 In contrast, three other systematic 
reviews found no effect for sex on the sleep duration and ACM risk relationship29, 43, 56, apart from a 
greater risk for obesity in longer sleeping women.43 Since long sleep duration may impair whole-body 
metabolism, increasing risk for obesity and T2DM57, the nature of risk may vary between men and 
women and  requires further investigation. 
 
Among the five included studies, longer sleep was defined as either ≥8h or ≥9h per night. Given that 
current sleep duration guidelines indicate that 7-9h of sleep are recommended for optimal health9, 10, 
longer sleep defined as ≥8h may not be long enough to adversely affect health. Explanations for why 
longer sleep may increase risk for ACM are debatable. Long sleep may be a response to poor sleep 
quality (i.e. fragmented sleep), high daytime sleepiness, elevated inflammatory markers or underlying 
conditions such as sleep disorders (e.g. obstructive sleep apnoea) or CVD.58 One might hypothesise 
that perhaps individuals with longer sleep (≥9h) unwittingly increased their sleep duration in response 
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to a pre-existing, undiagnosed underlying health condition predisposing them to premature mortality. 
In support of this hypothesis, it has been suggested that prolonged sleep might be a consequence of 
underlying diseases, frailty and worse health status, or be a part of the dying process.59 
The results of this study emphasise the need for sleep health management in the workplace, since the 
sleep health of employees may play as important a role on their future health outcomes as traditional 
CVD risk factors. Health screenings serve as a first step in workplace health promotion, where the 
awareness of health risks can lead to lifestyle change for the management and prevention of CVD. Of 
interest is that most workplace health programmes focus on physical activity, smoking and diet, 
despite the evidence showing that employees averaging ≤6h sleep were found to have a higher 
average number of health risks compared to those averaging 7-8h.24, 60 It is also clear that short sleep 
duration is associated with decreased workplace and public safety, sickness-related absenteeism61, 
lower information processing62, impaired cognition63, reduced task performance64 and diminished job 
performance.65 
 
Given that many sequelae of insufficient sleep duration may adversely impact on cardiovascular 
health, safety and productivity of employees, employers have a vested interest in providing workplace 
health programmes to support the workforce in achieving healthy sleep. Since our findings, and other 
recent evidence show a high prevalence of shorter sleep duration in working adults66, there is an 
urgency to address sleep as a public health issue in workplace settings. Obstacles that prevent 
employees from having sufficient time to obtain the recommended 7-9h of sleep, such as the duration 
and scheduling of work hours, and time taken to commute to work, are important focal points that 
may aid in the development and implementation of policies to improve employee sleep health. 
Strategies to promote sleep in the occupational health setting have been proposed, and include sleep 
education programmes that can be provided at workplaces; behavioural interventions to promote 
sleep; setting limits on the number of hours worked; where possible, encouraging teleworking to 
13 
 
facilitate more time for sleep; and modifying workplace environmental characteristics such as 
lighting.67-69  
 
Another avenue for supporting sleep enhancement include workplace policies that allow for more 
flexibility, whereby employees are given autonomy of when and where they work, as this has been 
shown to improve sleep health.70  Ultimately, employers and policy-makers are called to maximize the 
opportunity for employees to optimise their sleep health. One of the lessons learned from the global 
coronavirus pandemic in 2020 relates to sleep, work hours and workplace flexibility, since many 
employees were required to work from home. From a sleep perspective, there were reports of initial 
sleep extension71, 72 while maintaining work hours, which suggests catch-up sleep in response to 
chronic sleep deprivation. Anecdotal reasons for longer sleep when working from home related to 
reduced travel time and more flexible work schedules. Another observation was that some people 
significantly delayed their sleep timing and work hours when working from home. This indicated that 
under routine work conditions, some people were sleeping and working at a time of day that may not 
have suited their circadian rhythms and chronotype. More flexibility in sleep and work timing may 
thus afford employees the opportunity to adjust their sleep and work activities to a time of day that 
best suits their biology, a known factor in improving both sleep health and productivity. 
 
Strengths  
All studies included in this meta-analysis used a prospective study design, thus the misclassification of 
sleep duration attributable to recall bias was minimized. Most of the included studies were of 
relatively high quality, based on the NOS quality assessment (average of 7) and only included 




This review provides rationale for the inclusion of further studies representative of employees 
exclusively, particularly of studies representing the workforce of the African continent, which appear 
to be absent in the literature. The risk of dying from NCDs is highest in low- and middle-income 
countries, especially in sub-Saharan Africa73, therefore the impact of sleep duration in such countries, 
and its association with mortality are urgently needed to improve our knowledge of sleep health and 
disease in such populations. 
 
Limitations 
Although our findings are internally consistent with previous studies, we acknowledge several 
limitations. The primary limitation of these analyses is the small number of eligible studies available, 
which limited our statistical power. However, our study has highlighted a gap in the literature and 
underscores the importance of more sleep research needed in the field of occupational health. A 
second limitation is that in all but two studies36, 40, sleep duration was assessed at one point in time, 
and a single measurement of exposure may not capture the sustained effects of sleep duration over 
time, particularly if the reported period was shortly before death. Third, sleep duration in all studies 
was based on self-report and all but one study used 24h sleep, thus making it difficult to distinguish 
time asleep from time-in-bed, estimating the number and duration of naps or capturing sleep quality 
data. The consistency of assessments (all self-reported questionnaires) and outcomes (all obtained 
from official national registries) across studies, however, attenuates heterogeneity which would 
otherwise occur due to differences in methods. We acknowledge the limitations of self-reported sleep 
duration as an outcome variable. It has, however, routinely been used in similar studies25, 28-30, 74 and 
shown to correlate well with more objective measures (sleep diaries, actigraphy, and 
polysomnography).39, 75, 76 It is also worth considering that from a translational-research and practical 
perspective, self-reported sleep duration provides a more cost-effective measure to implement in 
workplace health programmes and can be more widely utilized. Fourth, the included studies all 
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presented mortality data based on different sleep duration categories (Supplementary Table S2) 
making it difficult to precisely match shorter, reference and longer sleep duration categories between 
studies. Finally, we recognise that a small number of occupations were represented by the participants 
in the reviewed studies, and the nature of the employment hours (e.g. night-time or rotational vs 
daytime shift work) was not recorded, thus limiting the generalisability of our results. 
 
Conclusions 
In this cohort of employed, urban individuals, self-reported shorter sleep was associated with a higher 
risk for both ACM and CVDM. Whether or not longer sleep is associated with a higher ACM risk, 
requires further investigations to unravel the mechanisms by which this association may contribute 
to increased mortality risk. Specifically, studies in which sleep is measured objectively and aspects of 
sleep quality are required. 
 
In the meantime, interventions such as workplace health programmes which include education, 
screening and support to improve sleep health and ensure an adequate sleep opportunity on an 
individual basis are warranted. Conversations around aspects of employment, such as working hours, 
commuting and industry, which likely limit sleep duration or reduce sleep quality, should be held. 
Finally, sleep needs to be considered in the management and treatment of comorbid factors such as 
obesity, hypertension, and T2DM, all of which are known to increase the risk for mortality. 
 
SO WHAT? 
What is already known on this topic? 
Suboptimal sleep has been identified as an important modifiable risk factor for cardiovascular and 
metabolic diseases and linked to mortality in the general population which include all ages, the 
unemployed, and people from rural communities. Since sleep patterns of employed individuals may 
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differ to those of their unemployed counterparts, the nature of their sleep-mortality relationship may 
vary. 
What does this article add? 
This review considered only studies of employed urban individuals younger than 65 years, and found 
that self-reported shorter sleep was associated with a higher risk for both all-cause and cardiovascular 
disease mortality. These findings highlight the role of adequate sleep in the urban labour force 
required to mitigate the increased risk of all-cause and cardiovascular disease mortality. 
What are the implications for health promotion practice or research? 
Workplace health programmes are encouraged to include education, screening and support to 
employees about improving sleep health, and to minimise sleep deprivation of employees. Our 
findings suggest that aspects of employment, such as working hours, commuting time and industry, 
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